Hjem › Brystkreft › Michigan › Lansing
Kliniske studier for Brystkreft i Lansing, MI
10 studier for Brystkreft søker deltakere på steder i og rundt Lansing (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- University of Michigan Health - Sparrow Lansing, Lansing
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RekruttererFase 3
- Karmanos Cancer Institute at McLaren Greater Lansing, Lansing
- University of Michigan Health - Sparrow Lansing, Lansing
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
RekruttererFase 3
- Karmanos Cancer Institute at McLaren Greater Lansing, Lansing
E-Mindfulness Approaches for Living After Breast Cancer
RekruttererFase 3
- University of Michigan Health - Sparrow Lansing, Lansing
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
RekruttererFase 2
- Herbert-Herman Cancer Center, Sparrow Hospital, Lansing
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
RekruttererFase 3
- Karmanos Cancer Institute at McLaren Greater Lansing, Lansing
A Study of the TheraBionic P1 Device in Breast Cancer
Rekrutterer
- Karmanos Cancer Institute at McLaren Greater Lansing, Lansing
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Lansing
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
RekruttererFase 3
- Karmanos Cancer Institute at McLaren Greater Lansing, Lansing
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
RekruttererObservasjonsstudie
- Sparrow Cancer Center, Lansing
Brystkreft-studier i andre byer
- New York City, NY134 studier
- Houston, TX126 studier
- Boston, MA111 studier
- Nashville, TN80 studier
- Los Angeles, CA72 studier
- Edison, NJ68 studier
- St. Louis, MO64 studier
- Durham, NC63 studier
- Queens, NY63 studier
- Chicago, IL58 studier
- Philadelphia, PA56 studier
- Dallas, TX55 studier
Andre studier i Lansing
- Lungekreft11 studier
- Prostatakreft10 studier
- Ikke-småcellet lungekreft9 studier
- Kreft (alle typer)6 studier
- Larynxcancer5 studier
- Blærekreft5 studier
- Sykdommer med overdreven søvnighet5 studier
- Kolorektal kreft4 studier
- Nyrekreft (nyrecellekarcinom)4 studier
- Tykktarmskreft4 studier
- Urotelial (overgangscelle) karcinom4 studier
- Plateepitelcancer i hode og hals4 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.